A resource for finance and business leaders seeking timely insights, practical guidance, and industry perspective. Explore content across accounting, tax, audit, and advisory topics to support informed decision-making.
For decades, companies have navigated the complexities involved in deducting research and experimental expenditures. The One Big Beautiful Bill (OBBB) Act with the newly released…
Life sciences companies face some of the highest costs and longest timelines for research and development. The One Big Beautiful Bill (OBBB) Act, with the…
Understanding the U.S. Market Entry Process for Life Science Companies For foreign life sciences companies, the decision to establish a presence in the United States…
The One Big Beautiful Bill Act (OBBBA), enacted in July 2025, introduces broad changes to international tax rules. These adjustments will affect U.S. corporations with…
Life science companies, particularly those in the start-up or growth phase, are challenged with balancing their core mission, e.g., advancing scientific discovery, with the complex…
Could your startup benefit from research and development (R&D) tax credits? Have you explored whether or not you qualify? Are you prepared to navigate tax…
In this article: Federal Tax Updates and Credits Expiring Provisions in the Tax Cuts and Jobs Act State Tax Challenges and Compliance International Tax Strategy…
AAFCPAs would like to make clients aware that the IRS has released final versions of two new Schedules K-2 & K-3 that should be included…
AAFCPAs would like to make clients aware that the IRS has issued early drafts of revisions to international tax Forms 5471 and FINCEN14 (formerly known…
